IBS and POTS: The Gut-Autonomic Connection Explained

Irritable bowel syndrome (IBS) and postural orthostatic tachycardia syndrome (POTS) co-occur at remarkably high rates — studies suggest 20–30% of POTS patients meet criteria for IBS, and conversely, a significant proportion of IBS patients have undiagnosed orthostatic intolerance. This is not coincidental: the gut and the autonomic nervous system are deeply intertwined, and dysfunction in one system almost inevitably affects the other.

The Enteric Nervous System: The Second Brain

The gut contains approximately 500 million neurons — more than the spinal cord — organized into the enteric nervous system (ENS). The ENS can function independently of the brain and spinal cord, regulating gut motility, secretion, and blood flow autonomously. However, it is also in constant bidirectional communication with the central autonomic nervous system via the vagus nerve and spinal afferents.

This bidirectional communication means that:

• Central autonomic dysfunction (POTS) directly affects gut function
• Gut dysfunction (IBS, SIBO, dysbiosis) directly affects central autonomic regulation
• Treatments that improve one system often improve the other

How POTS Affects the Gut

Splanchnic blood pooling. In POTS, blood pools in the splanchnic (abdominal) vasculature when standing, reducing venous return to the heart. This splanchnic pooling also impairs gut perfusion, contributing to nausea, bloating, and altered motility.

Reduced gut motility. The sympathetic nervous system (overactive in POTS) inhibits gut motility, while the parasympathetic system (underactive in POTS) promotes it. The sympathetic dominance of POTS slows gastric emptying and intestinal transit, contributing to nausea, early satiety, bloating, and constipation.

Mast cell activation. Many POTS patients have comorbid MCAS, and mast cells in the gut are particularly sensitive to the autonomic dysregulation of POTS. Mast cell activation in the gut produces the cramping, diarrhea, and bloating characteristic of IBS.

Vagal dysfunction. The vagus nerve is the primary parasympathetic nerve supplying the gut. Vagal dysfunction — common in POTS — impairs the gut's ability to regulate motility, secretion, and the gut-brain axis.

How IBS Affects Autonomic Function

Gut-brain axis dysregulation. The gut microbiome produces neurotransmitters (serotonin, GABA, dopamine precursors) and short-chain fatty acids that directly influence the central autonomic nervous system. Dysbiosis (altered microbiome composition) in IBS disrupts this signaling, contributing to autonomic instability.

Visceral hypersensitivity. IBS is characterized by visceral hypersensitivity — heightened pain perception from gut stimuli. This hypersensitivity involves the same small C-fibers that carry autonomic signals, and sensitization of these fibers can amplify autonomic dysregulation.

Inflammatory mediators. Low-grade intestinal inflammation in IBS produces cytokines that cross the gut-brain barrier and affect central autonomic regulation.

SIBO and Dysautonomia

Small intestinal bacterial overgrowth (SIBO) — an excess of bacteria in the small intestine — is significantly more common in POTS and dysautonomia patients than in the general population. The mechanisms are bidirectional:

• Slow gut motility from autonomic dysfunction allows bacterial overgrowth
• SIBO produces toxins (including hydrogen and methane gas) that further impair gut motility and autonomic function
• SIBO-derived lipopolysaccharide (LPS) crosses the gut barrier and triggers systemic inflammation and mast cell activation

SIBO testing (lactulose or glucose breath test) should be considered in POTS patients with significant IBS symptoms, particularly bloating, diarrhea, and nausea.

Treatment Approaches

Treating POTS improves IBS: Increasing sodium and fluid intake, compression garments, and POTS medications (particularly midodrine and fludrocortisone) improve splanchnic blood flow and reduce sympathetic dominance, often improving gut symptoms significantly.

Low-FODMAP diet: Reduces fermentable carbohydrates that feed gut bacteria and produce gas, reducing bloating and pain in IBS. Particularly useful in patients with SIBO.

Mast cell treatment: H1 + H2 antihistamines and mast cell stabilizers (cromolyn sodium, ketotifen) reduce gut mast cell activation, improving IBS symptoms in MCAS-driven IBS.

Vagal nerve stimulation: Devices and techniques that stimulate the vagus nerve (transcutaneous VNS, deep breathing, cold water immersion) can improve both autonomic function and gut motility.

Probiotics and microbiome support: Specific probiotic strains (Lactobacillus rhamnosus GG, Bifidobacterium longum) have evidence for IBS symptom reduction and may also support autonomic regulation through the gut-brain axis.

ChatDys resources: Log your gut symptoms alongside your autonomic symptoms in the Health Tracker to identify correlations. Review our SIBO and Dysautonomia article. Complete your Health Roadmap for a personalized treatment plan that addresses both IBS and POTS.